Title | Peak Annotation and Verification Engine for Untargeted LC-MS Metabolomics. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Wang, L, Xing, X, Chen, L, Yang, L, Su, X, Rabitz, H, Lu, W, Rabinowitz, JD |
Journal | Anal Chem |
Volume | 91 |
Issue | 3 |
Pagination | 1838-1846 |
Date Published | 2019 Feb 05 |
ISSN | 1520-6882 |
Abstract | Untargeted metabolomics can detect more than 10 000 peaks in a single LC-MS run. The correspondence between these peaks and metabolites, however, remains unclear. Here, we introduce a Peak Annotation and Verification Engine (PAVE) for annotating untargeted microbial metabolomics data. The workflow involves growing cells in C and N isotope-labeled media to identify peaks from biological compounds and their carbon and nitrogen atom counts. Improved deisotoping and deadducting are enabled by algorithms that integrate positive mode, negative mode, and labeling data. To distinguish metabolites and their fragments, PAVE experimentally measures the response of each peak to weak in-source collision induced dissociation, which increases the peak intensity for fragments while decreasing it for their parent ions. The molecular formulas of the putative metabolites are then assigned based on database searching using both m/ z and C/N atom counts. Application of this procedure to Saccharomyces cerevisiae and Escherichia coli revealed that more than 80% of peaks do not label, i.e., are environmental contaminants. More than 70% of the biological peaks are isotopic variants, adducts, fragments, or mass spectrometry artifacts yielding ∼2000 apparent metabolites across the two organisms. About 650 match to a known metabolite formula based on m/ z and C/N atom counts, with 220 assigned structures based on MS/MS and/or retention time to match to authenticated standards. Thus, PAVE enables systematic annotation of LC-MS metabolomics data with only ∼4% of peaks annotated as apparent metabolites. |
DOI | 10.1021/acs.analchem.8b03132 |
Alternate Journal | Anal. Chem. |
PubMed ID | 30586294 |
PubMed Central ID | PMC6501219 |
Grant List | DP1 DK113643 / DK / NIDDK NIH HHS / United States P30 CA072720 / CA / NCI NIH HHS / United States R01 CA163591 / CA / NCI NIH HHS / United States R50 CA211437 / CA / NCI NIH HHS / United States P30 DK019525 / DK / NIDDK NIH HHS / United States |